Original Research

Embedding lived experience into the development of a rehabilitation programme for individuals with chronic limb-threatening ischaemia

May 27, 2026

Introduction Public and patient involvement and engagement There is increasing recognition that involving individuals with lived experience of a health condition in public and patient involvement and engagement (PPIE) activities enhances the overall quality of the research.1-3 Beyond strengthening the research itself, evidence suggests that patient participation may benefit the individual directly, by developing their…

The ulcer with no fixed abode: barriers in accessing venous healthcare for individuals experiencing homelessness and using intravenous drugs in Bristol, UK

May 27, 2026

Introduction Unstable housing is a growing UK issue with 178,000 households assessed as homeless in 2023–24.1 Health inequalities exist for this population,2 with untimely healthcare utilisation often via Accident and Emergency (A&E) when health is critical resulting in long periods of inpatient care,3-5 higher mortality,2 National Health Service (NHS) financial strain6 and ‘tri-morbidity’ (poor physical…

Calculating and reducing the environmental impact of hybrid endovascular surgery

March 31, 2026

Introduction Background Climate change refers to long-term shifts in global temperatures and weather patterns, driven predominantly over the past two centuries by human activity, particularly the combustion of fossil fuels. The release of greenhouse gases such as carbon dioxide (CO2) and methane (CH4) traps heat within the atmosphere, raising global temperatures,1 which is known as…

A national UK-wide survey of tranexamic acid use in vascular surgery

February 27, 2026

Introduction Tranexamic acid (TXA) is a synthetic lysine analogue that inhibits fibrinolysis and reduces surgical bleeding by stabilising clot formation.1 Large randomised trials have demonstrated its efficacy in a range of clinical settings including trauma, postpartum haemorrhage and cardiac surgery, where TXA has been associated with reductions in mortality, critical bleeding and transfusion requirements.2-5 National…

Development of a rehabilitation programme for individuals with chronic limb threatening ischaemia post revascularisation (HOPE): a modified Delphi study

February 23, 2026

Introduction Peripheral artery disease (PAD) affects over 236 million globally,1 equating to approximately 20% of individuals aged over 60 in the UK. Already identified as the leading contributor to vascular service demand within secondary care,2 the prevalence of this condition is projected to increase by 50% by the year 2045.3 The most severe manifestation of…